cti-mcpFinanceResearch & Datahjsh200219FlicenseAqualityDmaintenanceEnables to analyze Korean pharma/biotech stocks using clinical trial data from ClinicalTrials.gov and market data from Naver Finance, providing 100-point scoring, decision labels, and technical indicators. Updated 4 months ago (2026-05-01 18:18 UTC)10-